Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production

被引:609
作者
Moffatt, Jennifer H. [1 ]
Harper, Marina [1 ,2 ]
Harrison, Paul [3 ]
Hale, John D. F. [4 ]
Vinogradov, Evgeny [5 ]
Seemann, Torsten [3 ]
Henry, Rebekah [1 ]
Crane, Bethany [1 ]
Michael, Frank St. [5 ]
Cox, Andrew D. [5 ]
Adler, Ben [1 ,2 ,3 ]
Nation, Roger L. [4 ]
Li, Jian [4 ]
Boyce, John D. [1 ,2 ]
机构
[1] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia
[2] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia
[3] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3800, Australia
[4] Monash Univ, Facil Antiinfect Drug Dev & Innovat Drug Delivery, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia
[5] CNR, Inst Biol Sci, Ottawa, ON, Canada
基金
英国医学研究理事会;
关键词
OUTER-MEMBRANE; POLYMYXIN-B; 1ST STEP; HETERORESISTANCE; EMERGENCE; INSERTION; IDENTIFICATION; ANTIBIOTICS; MENINGITIS; BACTERIUM;
D O I
10.1128/AAC.00834-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Infections caused by multidrug-resistant (MDR) Gram-negative bacteria represent a major global health problem. Polymyxin antibiotics such as colistin have resurfaced as effective last-resort antimicrobials for use against MDR Gram-negative pathogens, including Acinetobacter baumannii. Here we show that A. baumannii can rapidly develop resistance to polymyxin antibiotics by complete loss of the initial binding target, the lipid A component of lipopolysaccharide (LPS), which has long been considered to be essential for the viability of Gram-negative bacteria. We characterized 13 independent colistin-resistant derivatives of A. baumannii type strain ATCC 19606 and showed that all contained mutations within one of the first three genes of the lipid A biosynthesis pathway: lpxA, lpxC, and lpxD. All of these mutations resulted in the complete loss of LPS production. Furthermore, we showed that loss of LPS occurs in a colistin-resistant clinical isolate of A. baumannii. This is the first report of a spontaneously occurring, lipopolysaccharide-deficient, Gram-negative bacterium.
引用
收藏
页码:4971 / 4977
页数:7
相关论文
共 39 条
[1]   Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System [J].
Adams, Mark D. ;
Nickel, Gabrielle C. ;
Bajaksouzian, Saralee ;
Lavender, Heather ;
Murthy, A. Rekha ;
Jacobs, Michael R. ;
Bonomo, Robert A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) :3628-3634
[2]  
[Anonymous], 2012, Molecular Cloning: A Laboratory Manual
[3]   Identification of Novel Glycosyltransferases Required for Assembly of the Pasteurella multocida A:1 Lipopolysaccharide and Their Involvement in Virulence [J].
Boyce, John D. ;
Harper, Marina ;
Michael, Frank St. ;
John, Marietta ;
Aubry, Annie ;
Parnas, Henrietta ;
Logan, Susan M. ;
Wilkie, Ian W. ;
Ford, Mark ;
Cox, Andrew D. ;
Adler, Ben .
INFECTION AND IMMUNITY, 2009, 77 (04) :1532-1542
[4]   Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin [J].
Carlos Hernan, Rodriguez ;
Karina, Bombicino ;
Gabriela, Granados ;
Marcela, Nastro ;
Carlos, Vay ;
Angela, Famiglietti .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 65 (02) :188-191
[5]   Gram-negative outer and inner membrane models: Insertion of cyclic cationic lipopeptides [J].
Clausell, Adria ;
Garcia-Subirats, Maria ;
Pujol, Montserrat ;
Busquets, M. Antonia ;
Rabanal, Francesc ;
Cajal, Yolanda .
JOURNAL OF PHYSICAL CHEMISTRY B, 2007, 111 (03) :551-563
[6]  
Clinical and Laboratory Standards Institute, 2008, M100S18 CLIN LAB STA
[7]   Genetic and phenotypic analysis of Acinetobacter baumannii insertion derivatives generated with a transposome system [J].
Dorsey, CW ;
Tomaras, AP ;
Actis, LA .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2002, 68 (12) :6353-6360
[8]   Polymyxin B sulfate and colistin: Old antibiotics for emerging multiresistant gram-negative bacteria [J].
Evans, ME ;
Feola, DJ ;
Rapp, RP .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) :960-967
[9]   Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004) [J].
Gales, AC ;
Jones, RN ;
Sader, HS .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (04) :315-321
[10]  
GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394